Predicting Retinopathy of Prematurity Risk Using Plasma Levels of Insulin-like Growth Factor 1 (IGF1), Tumor Necrosis Factor-Alpha (TNF-Alpha), and Neonatal Parameters
-
Published:2024-08-01
Issue:4
Volume:14
Page:1515-1528
-
ISSN:2039-7283
-
Container-title:Clinics and Practice
-
language:en
-
Short-container-title:Clinics and Practice
Author:
Cioboata Daniela Mariana12, Costescu Oana Cristina12, Manea Aniko Maria1, Doandes Florina Marinela1, Zaharie Mihaela1, Popa Zoran Laurentiu3, Costescu Sergiu3, Stoica Florina4, Boia Marioara1
Affiliation:
1. Department of Neonatology, “Victor Babes” University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania 2. Doctoral School Department, “Victor Babes” University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania 3. Department of Obstetrics and Gynecology, “Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania 4. Department of Ophthalmology, Emergency Municipal Clinical Hospital, 300172 Timisoara, Romania
Abstract
Background/Objectives: Retinopathy of Prematurity (ROP) remains a leading cause of vision impairment in premature infants, especially those with Respiratory Distress Syndrome (RDS) necessitating respiratory support. This study aimed to identify correlations between plasma levels of Insulin-like Growth Factor 1 (IGF1) and Tumor Necrosis Factor-alpha (TNF-alpha), and the risk of developing ROP. Additionally, it explored the association of ROP severity grades with plasma levels of glucose, lactate dehydrogenase (LDH), creatin phosphokinase (CPK), and other biomarkers, aiming to uncover predictive markers for ROP risk and severity in this population. Methods: This prospective study included premature neonates admitted with RDS requiring respiratory support, conducted over 18 months at the Neonatal Intensive Care Unit of the Louis Turcanu Emergency Clinical Hospital for Children, Timisoara. Plasma levels of IGF1 and TNF-alpha were measured on days 1 and 14 post-birth, alongside the initial assessment of glucose, LDH, and CPK levels. Results: Significant correlations were observed between lower gestational age and elevated LDH levels on day 7–10 (rho = −0.341, p = 0.0123) and between TNF-alpha levels at 2 weeks and ROP severity (rho = 0.512, p = 0.0004). Elevated IGF1 levels were protective against ROP, with Beta coefficients of 0.37 (p = 0.0032) for the first collection and 0.32 (p = 0.0028) for the second, suggesting their potential as biomarkers for ROP risk assessment. Higher levels of TNF-alpha at 2 weeks were associated with an increased risk of ROP (Beta = −0.45, p = 0.0014), whereas higher IGF1 levels offered protective effects against ROP, with Beta coefficients of 0.37 (p = 0.0032) for the first collection and 0.32 (p = 0.0028) for the second. Elevated LDH levels on day 7–10 post-birth were linked to an increased risk of ROP (Beta = 0.29, p = 0.0214). Conclusions: These findings highlight the potential of IGF1 and TNF-alpha as predictive biomarkers for ROP, offering avenues for early intervention and improved management strategies in this high-risk group.
Reference28 articles.
1. Retinopathy of prematurity: A study of prevalence and risk factors;Hakeem;Middle East. Afr. J. Ophthalmol.,2012 2. Retinopathy of prematurity: Past, present and future;Shah;World J. Clin. Pediatr.,2016 3. Latest Trends in Retinopathy of Prematurity: Research on Risk Factors, Diagnostic Methods and Therapies;Tiutiuca;Int. J. Gen. Med.,2023 4. Pathophysiology of retinopathy of prematurity;Strube;Saudi J. Ophthalmol.,2022 5. Kaštelan, S., Orešković, I., Bišćan, F., Kaštelan, H., and Gverović Antunica, A. (2020). Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochem. Med., 30.
|
|